QUESTION: For which indication has inotersen been approved?

IDEAL_ANSWER:
- Inoteresen has been approved for patients in stage 1 and stage 2 hereditary transthyretin amyloidosis polyneuropathy.

EXACT_ANSWER:
- stage 1 and stage 2 hereditary transthyretin amyloidosis polyneuropathy